APA (7th ed.) Citation

Tsyganov, M. M., Rodionov, E. O., Ibragimova, M. K., Miller, S. V., Cheremisina, O. V., Frolova, I. G., . . . Litvyakov, N. V. Personalized prescription of chemotherapy based on assessment of mRNA expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 genes in tumors compared to standard chemotherapy in the treatment of non-small-cell lung cancer. Journal of personalized medicine, 2022, .

Chicago Style (17th ed.) Citation

Tsyganov, Matvey M., Evgeniy O. Rodionov, Marina K. Ibragimova, Sergey V. Miller, Olga V. Cheremisina, Irina G. Frolova, Sergey A. Tuzikov, and Nicolay V. Litvyakov. "Personalized Prescription of Chemotherapy Based on Assessment of MRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-small-cell Lung Cancer." Journal of Personalized Medicine 2022 ().

MLA (8th ed.) Citation

Tsyganov, Matvey M., et al. "Personalized Prescription of Chemotherapy Based on Assessment of MRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-small-cell Lung Cancer." Journal of Personalized Medicine, 2022, .